Registry for people with idiopathic pulmonary fibrosis in Korea
Part of Lungs & breathing clinical trials.
This study is a registry that collects health information from people diagnosed with idiopathic pulmonary fibrosis (IPF). It may help researchers better understand IPF and how it changes over time, even if it doesn’t involve a new medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with idiopathic pulmonary fibrosis (IPF).
- Your IPF diagnosis was agreed on by a team of specialists in a multidisciplinary review.
- You do not have other non-IPF lung scarring diseases.
- Your lung scarring is not caused by a connective tissue disease (like lupus or rheumatoid arthritis).
- Your lung scarring is not caused by an exposure (like certain dusts, chemicals, or radiation).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study builds a community registry to learn about people affected by pulmonary fibrosis and related lung conditions, including patients, caregivers, and close family. By joining, you help researchers better understand needs and experiences in the real world.
This study looks at people with a condition called idiopathic pulmonary fibrosis (IPF), which causes lung scarring. Researchers want to develop a tool to predict how the disease will progress, so they will collect health data over time to see what factors affect outcomes.
This study looks at genetic (DNA) and protein changes over time in people with idiopathic pulmonary fibrosis, to better understand how the disease progresses. Your participation may help researchers learn patterns that could guide future care.
This trial is for people with scarring lung disease (pulmonary fibrosis) in Ireland. It aims to better understand and care for the condition, especially in families. The study will look at medical data and may help improve diagnosis and treatment.
This study looks at what causes familial (inherited) pulmonary fibrosis by studying relatives who are not yet diagnosed with the lung disease. You may help researchers understand risk and early changes in the lungs within families.
This study looks at the symptoms and patterns of idiopathic pulmonary fibrosis (IPF), a lung condition that causes scarring. By joining, you help doctors better understand the disease, which may lead to better care.
Hear when a new Idiopathic Pulmonary Fibrosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.